A 64-year-old female with schizophrenia and chronic kidney disease is being considered for erythropoietin-stimulating agent (ESA) therapy with epoetin alfa. Her current medications include clozapine and hydrochlorothiazide. What is the most common side effect of epoetin alfa therapy?
